Omnicell, Inc. (NASDAQ: OMCL) today announced that MUSC Health has
chosen the Company’s industry-leading medication management platform to
support their sterile compounding operations in Central Pharmacy, as
well as expanding their footprint for automated dispensing cabinets in
patient care areas.
MUSC Health will be implementing Omnicell’s Robotic
IV Insourcing SolutionTM(RIIS) to bring
sterile compounding in-house as part of the health system’s Central
Pharmacy operations. This unique program combines advanced robotic
technology, data intelligence, and expertly trained pharmacy technician
staff into a comprehensive, turnkey package that provides a streamlined
path for hospitals to insource their sterile compounding to enhance
patient safety while reducing overall cost and reliance on outsourcers.
In patient care areas within MUSC Health’s new children’s and women’s
facility, Shawn Jenkins Children’s Hospital and Pearl Tourville Women’s
Pavilion, the health system will be upgrading to Omnicell’s XT
Series Automated Dispensing Cabinets to help improve workflow
efficiency for both nursing and pharmacy, while helping to increase
medication accountability and patient safety.
“We are continually looking for opportunities to improve processes that
support delivery of the best care for our patients,” said Heather
Easterling, PharmD, MBA, Administrator of Pharmacy Services for MUSC
Health. “Omnicell’s technologies, including novel programs like RIIS,
give us the tools and resources we need to create safer, more efficient
medication management across our health system.”
Through RIIS, MUSC Health will also have access to novel data services,
including REINVENTTM,
a first-of-a-kind global clinical registry that utilizes IV preparation
data from sites around the world to help users track performance,
identify best practices and gather insights to maximize the value of IV
automation technology. Omnicell’s Formulary
Tool Kit will provide the health system access to cGMP stability
studies to extend beyond use dates using a proven, systematic,
repeatable process.
These types of rich data insights are part of Omnicell’s larger vision
for Autonomous Pharmacy, a roadmap designed to develop a zero error,
fully automated medication management infrastructure, leveraging
automation, data intelligence, and expert services to empower
pharmacists, nurses, clinicians, and pharmacy staff to focus on patient
and clinician satisfaction.
“At Omnicell, we are committed to helping our customers drive improved
outcomes. Our advanced technology is a key piece of that equation, but
equally important are the data insights and expert resources we provide
to help enhance efficiency and support patient safety,” said Scott
Seidelmann, executive vice president and chief commercial officer at
Omnicell.
About MUSC Health
As the clinical health system of the Medical University of South
Carolina (MUSC), MUSC Health is dedicated to delivering the highest
quality patient care available, while training generations of competent,
compassionate health care providers to serve the people of South
Carolina and beyond. Comprising some 1,600 beds, more than 100 outreach
sites, the MUSC College of Medicine, the physicians’ practice plan, and
nearly 275 telehealth locations, MUSC Health owns and operates eight
hospitals situated in Charleston, Chester, Florence, Lancaster and
Marion counties. In 2018, for the fourth consecutive year, U.S. News &
World Report named MUSC Health the number one hospital in South
Carolina. To learn more about clinical patient services, visit http://muschealth.org.
Founded in 1824, MUSC and its affiliates have collective annual budgets
of $3 billion. The more than 17,000 MUSC team members include
world-class faculty, physicians, specialty providers and scientists who
deliver groundbreaking education, research, technology and patient care.
For information on academic programs, visit musc.edu.
About Omnicell
Since 1992, Omnicell has been inspired to create safer and more
efficient ways to manage medications across all care settings. As a
leading provider of solutions across the continuum of care, we offer a
path to fully automated medication management infrastructure, powered by
a cloud data platform that supports improved patient care, fewer errors,
enhanced safety, and new opportunities for growth.
Our vision for the Autonomous Pharmacy integrates a comprehensive set of
solutions powered by the Omnicell Cloud Data Platform across three key
areas: Automation – solutions designed to digitize and streamline
workflows; Intelligence – actionable insights to better understand
medication usage and improve pharmacy supply chain management; and Work
– expert services that serve as an extension of pharmacy operations to
support improved efficiency, regulatory compliance, and patient outcomes.
Over 5,500 facilities worldwide use Omnicell automation and analytics
solutions to increase operational efficiency, reduce medication errors,
deliver actionable intelligence, and improve patient safety. And more
than 40,000 institutional and retail pharmacies across North America and
the United Kingdom leverage Omnicell’s innovative medication adherence
solutions to improve patient engagement and adherence to prescriptions,
helping to reduce costly hospital readmissions.
To learn more about Omnicell and our Autonomous Pharmacy vision, please
visit omnicell.com.
OMCL-G
Editor’s Notes:
1. All Omnicell news releases (financial, acquisitions, products,
technology etc.) are issued exclusively by Business Wire and are
immediately thereafter posted on the company’s external website, omnicell.com.
2. Omnicell and the Omnicell logo design are registered trademarks of
Omnicell, Inc.
3. All other brand or product names may be trademarks or registered
trademarks of their respective companies.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190522005157/en/